Cat.#: ACPP-1717
| Despition | LIF Mouse Recombinant |
| SIZE | 3 x 2 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1812 | Human IMPA1 Protein (AC1812) | 5 µg | inquiry |
| ACPP-1828 | Human EPHA2 Protein (AC1828) | 2 µg | inquiry |
| ACPP-1580 | Mouse LGALS9 Protein (AC1580) | 2 µg | inquiry |
| ACPP-1092 | Synthetic Nanodisc Human GLP-1R Protein (AC1092) | 10 µg | inquiry |
| ACPP-1227 | Pax2 Blocking Peptide (AC1227) | 250 µg | inquiry |
| ACPP-1559 | Human LIN7C Protein (AC1559) | 5 µg | inquiry |
| ACPP-1124 | Recombinant Human MAP2C Protein (AC1124) | 25 µl | inquiry |
| ACPP-1337 | Neurochondrin Blocking Peptide (AC1337) | 250 µg | inquiry |
| ACPP-1644 | Human Vimentin Protein (AC1644) | 20 µg | inquiry |
| ACPP-1011 | Recombinant Human FGF1 Protein (AC1011) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.